The sleep apnea devices market size has grown strongly in recent years. It will grow from $8.37 billion in 2025 to $9.05 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to rising awareness of sleep apnea, increasing prevalence of obesity, growth of sleep laboratories, improvement in CPAP technology, expansion of healthcare insurance coverage.
The sleep apnea devices market size is expected to see strong growth in the next few years. It will grow to $12.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to growth of home healthcare, rising geriatric population, increasing adoption of portable sleep devices, higher healthcare spending, technological advancements in sleep monitoring. Major trends in the forecast period include home-based sleep apnea diagnosis, rising adoption of portable CPAP devices, growing preference for non-invasive oral appliances, increasing focus on patient comfort and compliance, expansion of sleep clinics and diagnostic centers.
The rising prevalence of obesity is expected to drive the growth of the sleep apnea devices market in the coming years. Obesity is a medical condition characterized by excessive body fat accumulation that poses health risks, commonly measured using the body mass index (BMI). Obesity is a significant risk factor for sleep apnea, and the global increase in obesity rates has contributed to the higher prevalence of this disorder. Consequently, there is growing demand for devices that can effectively manage sleep apnea. For instance, in May 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, an estimated 64.5 percent of adults in England were overweight or living with obesity in 2023-2024, up from 64 percent in 2022-2023. Therefore, the rising obesity rates are boosting the sleep apnea devices market.
Major players in the sleep apnea devices market are embracing a strategic partnership approach to facilitate home-based sleep apnea detection. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefit. For instance, in May 2023, Signifier Medical Technologies LLC, a US-based medical technology company, announced a partnership with Sunrise, a Hong Kong-based healthcare technology company. This collaboration integrates Sunrise's AI solutions with Signifier Medical's eXciteOSA daytime sleep apnea therapy technologies, enhancing patient care through more efficient diagnosis and treatments. The joint offering includes personalized home sleep testing and a patient management portal, empowering healthcare professionals to gather comprehensive information on patients' daily clinical experiences and optimize outcomes.
In July 2024, EnsoData, a U.S.-based software company, acquired sleep testing diagnostic technology from Resonea for an undisclosed sum. This acquisition is intended to significantly enhance EnsoData's capabilities in screening and diagnosing sleep apnea. The focus of this acquisition is to reduce costs and improve access to systematic screening for sleep apnea. Resonea is a company based in Arizona that specializes in sleep diagnostics.
Major companies operating in the sleep apnea devices market are ResMed Inc., Fisher And Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., BMC Medical Co. Ltd., Lowenstein Medical Technology GmbH Co. KG, DeVilbiss Healthcare LLC, Drive DeVilbiss Healthcare, APEX Medical Corp., 3B Medical Inc., HOFFRICHTER GmbH, Circadiance LLC, Sleepnet Corporation, Oventus Medical Ltd., Inspire Medical Systems Inc., Provent Sleep Therapy LLC, Bleep LLC, Natus Medical Incorporated, Compumedics Limited, Braebon Medical Corporation, Cadwell Industries Inc., Itamar Medical Ltd., Somnoware Healthcare Systems Inc.
North America was the largest region in the sleep apnea devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sleep apnea devices market during the forecast period. The regions covered in the sleep apnea devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sleep apnea devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the sleep apnea devices market by increasing the prices of imported electronic components, sensors, and medical-grade plastics used in CPAP machines, wearable actigraphy systems, and sleep screening devices. These impacts are most visible across PAP devices, oxygen devices, and sleep monitoring systems, particularly in Asia-Pacific and North American regions that rely heavily on cross-border manufacturing and supply chains. Higher import duties have led to elevated product prices and slower replacement cycles in hospitals, diagnostic centers, and home healthcare settings. However, tariffs are also encouraging manufacturers to localize production, strengthen regional supply networks, and invest in cost-efficient device designs, which may support long-term market stability and innovation.
The sleep apnea devices market research report is one of a series of new reports that provides sleep apnea devices market statistics, including sleep apnea devices industry global market size, regional shares, competitors with a sleep apnea devices market share, detailed sleep apnea devices market segments, market trends and opportunities, and any further data you may need to thrive in the sleep apnea devices industry. This sleep apnea devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Sleep apnea devices encompass a range of advanced equipment, notably Continuous Positive Airway Pressure (CPAP) machines, designed to mitigate snoring and prevent sleep apnea. These CPAP devices precisely administer optimal air pressure to a mask, ensuring the maintenance of open upper airway passages.
Key categories within the sleep apnea devices market include airway clearance systems, adaptive servo-ventilation (ASV), positive airway pressure (PAP) devices, oral appliances, oxygen devices, sleep screening devices, actuation systems, polysomnography (PSG) devices, and respiratory polygraphs. Airway-clearing systems, a vital component, aid in the expulsion of thick mucus, facilitating coughing or huffing to clear the lungs. This technology is instrumental in addressing conditions such as obstructive sleep apnea syndrome, central sleep apnea syndrome, and complex sleep apnea syndrome. Targeting diverse age demographics, including pediatric, adult, and geriatric populations, these devices find application across various healthcare settings, such as hospitals, clinics, diagnostic centers, ambulatory care centers, specialty care centers, and home healthcare.
The sleep apnea devices market consists of sales of automatic positive airway pressure, biPAP machines, autoPAP machines, positional therapy devices, and implant systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The sleep apnea devices market size is expected to see strong growth in the next few years. It will grow to $12.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to growth of home healthcare, rising geriatric population, increasing adoption of portable sleep devices, higher healthcare spending, technological advancements in sleep monitoring. Major trends in the forecast period include home-based sleep apnea diagnosis, rising adoption of portable CPAP devices, growing preference for non-invasive oral appliances, increasing focus on patient comfort and compliance, expansion of sleep clinics and diagnostic centers.
The rising prevalence of obesity is expected to drive the growth of the sleep apnea devices market in the coming years. Obesity is a medical condition characterized by excessive body fat accumulation that poses health risks, commonly measured using the body mass index (BMI). Obesity is a significant risk factor for sleep apnea, and the global increase in obesity rates has contributed to the higher prevalence of this disorder. Consequently, there is growing demand for devices that can effectively manage sleep apnea. For instance, in May 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, an estimated 64.5 percent of adults in England were overweight or living with obesity in 2023-2024, up from 64 percent in 2022-2023. Therefore, the rising obesity rates are boosting the sleep apnea devices market.
Major players in the sleep apnea devices market are embracing a strategic partnership approach to facilitate home-based sleep apnea detection. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefit. For instance, in May 2023, Signifier Medical Technologies LLC, a US-based medical technology company, announced a partnership with Sunrise, a Hong Kong-based healthcare technology company. This collaboration integrates Sunrise's AI solutions with Signifier Medical's eXciteOSA daytime sleep apnea therapy technologies, enhancing patient care through more efficient diagnosis and treatments. The joint offering includes personalized home sleep testing and a patient management portal, empowering healthcare professionals to gather comprehensive information on patients' daily clinical experiences and optimize outcomes.
In July 2024, EnsoData, a U.S.-based software company, acquired sleep testing diagnostic technology from Resonea for an undisclosed sum. This acquisition is intended to significantly enhance EnsoData's capabilities in screening and diagnosing sleep apnea. The focus of this acquisition is to reduce costs and improve access to systematic screening for sleep apnea. Resonea is a company based in Arizona that specializes in sleep diagnostics.
Major companies operating in the sleep apnea devices market are ResMed Inc., Fisher And Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., BMC Medical Co. Ltd., Lowenstein Medical Technology GmbH Co. KG, DeVilbiss Healthcare LLC, Drive DeVilbiss Healthcare, APEX Medical Corp., 3B Medical Inc., HOFFRICHTER GmbH, Circadiance LLC, Sleepnet Corporation, Oventus Medical Ltd., Inspire Medical Systems Inc., Provent Sleep Therapy LLC, Bleep LLC, Natus Medical Incorporated, Compumedics Limited, Braebon Medical Corporation, Cadwell Industries Inc., Itamar Medical Ltd., Somnoware Healthcare Systems Inc.
North America was the largest region in the sleep apnea devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sleep apnea devices market during the forecast period. The regions covered in the sleep apnea devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sleep apnea devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the sleep apnea devices market by increasing the prices of imported electronic components, sensors, and medical-grade plastics used in CPAP machines, wearable actigraphy systems, and sleep screening devices. These impacts are most visible across PAP devices, oxygen devices, and sleep monitoring systems, particularly in Asia-Pacific and North American regions that rely heavily on cross-border manufacturing and supply chains. Higher import duties have led to elevated product prices and slower replacement cycles in hospitals, diagnostic centers, and home healthcare settings. However, tariffs are also encouraging manufacturers to localize production, strengthen regional supply networks, and invest in cost-efficient device designs, which may support long-term market stability and innovation.
The sleep apnea devices market research report is one of a series of new reports that provides sleep apnea devices market statistics, including sleep apnea devices industry global market size, regional shares, competitors with a sleep apnea devices market share, detailed sleep apnea devices market segments, market trends and opportunities, and any further data you may need to thrive in the sleep apnea devices industry. This sleep apnea devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Sleep apnea devices encompass a range of advanced equipment, notably Continuous Positive Airway Pressure (CPAP) machines, designed to mitigate snoring and prevent sleep apnea. These CPAP devices precisely administer optimal air pressure to a mask, ensuring the maintenance of open upper airway passages.
Key categories within the sleep apnea devices market include airway clearance systems, adaptive servo-ventilation (ASV), positive airway pressure (PAP) devices, oral appliances, oxygen devices, sleep screening devices, actuation systems, polysomnography (PSG) devices, and respiratory polygraphs. Airway-clearing systems, a vital component, aid in the expulsion of thick mucus, facilitating coughing or huffing to clear the lungs. This technology is instrumental in addressing conditions such as obstructive sleep apnea syndrome, central sleep apnea syndrome, and complex sleep apnea syndrome. Targeting diverse age demographics, including pediatric, adult, and geriatric populations, these devices find application across various healthcare settings, such as hospitals, clinics, diagnostic centers, ambulatory care centers, specialty care centers, and home healthcare.
The sleep apnea devices market consists of sales of automatic positive airway pressure, biPAP machines, autoPAP machines, positional therapy devices, and implant systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Sleep Apnea Devices Market Characteristics
3. Sleep Apnea Devices Market Supply Chain Analysis
4. Global Sleep Apnea Devices Market Trends and Strategies
5. Sleep Apnea Devices Market Analysis of End Use Industries
7. Global Sleep Apnea Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Sleep Apnea Devices Total Addressable Market (TAM) Analysis for the Market
9. Sleep Apnea Devices Market Segmentation
10. Sleep Apnea Devices Market Regional and Country Analysis
11. Asia-Pacific Sleep Apnea Devices Market
12. China Sleep Apnea Devices Market
13. India Sleep Apnea Devices Market
14. Japan Sleep Apnea Devices Market
15. Australia Sleep Apnea Devices Market
16. Indonesia Sleep Apnea Devices Market
17. South Korea Sleep Apnea Devices Market
18. Taiwan Sleep Apnea Devices Market
19. South East Asia Sleep Apnea Devices Market
20. Western Europe Sleep Apnea Devices Market
21. UK Sleep Apnea Devices Market
22. Germany Sleep Apnea Devices Market
23. France Sleep Apnea Devices Market
24. Italy Sleep Apnea Devices Market
25. Spain Sleep Apnea Devices Market
26. Eastern Europe Sleep Apnea Devices Market
27. Russia Sleep Apnea Devices Market
28. North America Sleep Apnea Devices Market
29. USA Sleep Apnea Devices Market
30. Canada Sleep Apnea Devices Market
31. South America Sleep Apnea Devices Market
32. Brazil Sleep Apnea Devices Market
33. Middle East Sleep Apnea Devices Market
34. Africa Sleep Apnea Devices Market
36. Sleep Apnea Devices Market Competitive Landscape and Company Profiles
37. Sleep Apnea Devices Market Other Major and Innovative Companies
40. Sleep Apnea Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Sleep Apnea Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses sleep apnea devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for sleep apnea devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sleep apnea devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Positive Airway Pressure (PAP) Devices; Adaptive Servo-Ventilation (ASV) Devices; Oral Appliances; Sleep Apnea Diagnostic Devices; PAP Interfaces And Accessories2) By Patient Type: Pediatric; Adult; Geriatric
3) By Disease: Obstructive Sleep Apnea Syndrome; Central Sleep Apnea Syndrome; Complex Sleep Apnea Syndrome
4) By End User: Hospital And Clinics; Ambulatory Care Centers; Specialty Care Center; Home Healthcare
Subsegments:
1) By Positive Airway Pressure (PAP) Devices: Continuous Positive Airway Pressure (CPAP) Machines; Bi-Level Positive Airway Pressure (BiPAP) Machines; Auto-Adjusting Positive Airway Pressure (APAP) Machines2) By Adaptive Servo-Ventilation (ASV) Devices: Fixed Backup Rate ASV Devices; Auto Backup Rate ASV Devices; Variable Pressure Support ASV Devices
3) By Oral Appliances: Mandibular Advancement Devices (MADs); Tongue-Retaining Devices (TRDs)
4) By Sleep Apnea Diagnostic Devices: Polysomnography (PSG) Devices; Respiratory Polygraph Devices; Home Sleep Apnea Testing (HSAT) Devices
5) By PAP Interfaces And Accessories: PAP Masks (Nasal Masks; Nasal Pillow Masks; Full-Face Masks); Headgear And Chin Straps; Tubing And Connectors; Heated Humidifiers; Filters And Disposable Accessories
Companies Mentioned: ResMed Inc.; Fisher And Paykel Healthcare Corporation Limited; Koninklijke Philips N.V.; BMC Medical Co. Ltd.; Lowenstein Medical Technology GmbH Co. KG; DeVilbiss Healthcare LLC; Drive DeVilbiss Healthcare; APEX Medical Corp.; 3B Medical Inc.; HOFFRICHTER GmbH; Circadiance LLC; Sleepnet Corporation; Oventus Medical Ltd.; Inspire Medical Systems Inc.; Provent Sleep Therapy LLC; Bleep LLC; Natus Medical Incorporated; Compumedics Limited; Braebon Medical Corporation; Cadwell Industries Inc.; Itamar Medical Ltd.; Somnoware Healthcare Systems Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Sleep Apnea Devices market report include:- ResMed Inc.
- Fisher And Paykel Healthcare Corporation Limited
- Koninklijke Philips N.V.
- BMC Medical Co. Ltd.
- Lowenstein Medical Technology GmbH Co. KG
- DeVilbiss Healthcare LLC
- Drive DeVilbiss Healthcare
- APEX Medical Corp.
- 3B Medical Inc.
- HOFFRICHTER GmbH
- Circadiance LLC
- Sleepnet Corporation
- Oventus Medical Ltd.
- Inspire Medical Systems Inc.
- Provent Sleep Therapy LLC
- Bleep LLC
- Natus Medical Incorporated
- Compumedics Limited
- Braebon Medical Corporation
- Cadwell Industries Inc.
- Itamar Medical Ltd.
- Somnoware Healthcare Systems Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.05 Billion |
| Forecasted Market Value ( USD | $ 12.54 Billion |
| Compound Annual Growth Rate | 8.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
